Scottish biotech firm inks deal with Japan's NIPRO to co develop cancer drug

Scottish firm TC BioPharm has inked a strategic collaboration with the Japan’s NIPRO Corporation to co-d...

February 8, 2018 | Thursday | News
Immunologist Max Cooper receives 2018 Japan Prize

The Japan Prize Foundation has announced Max D. Cooper, MD, as a laureate of the 2018 Japan Prize. Cooper will receive a...

February 6, 2018 | Tuesday | News
Japan, Australia researchers work on early Alzheimer’s detection

Researchers at Florey Institute of Neuroscience and Mental Health, and University of Melbourne, Australia and Japanese N...

February 6, 2018 | Tuesday | News
Scientists develop technology for studying blood vessel formation

A team of researchers at the Institute of Industrial Science (IIS), the University of Tokyo, CNRS and INSERM, has report...

February 1, 2018 | Thursday | News
BiomX in-licenses novel bacterial targets for IBD treatment

BiomX Ltd., a microbiome company, announced that it has exclusively sub-licensed a set of bacterial targets from JSR Cor...

January 31, 2018 | Wednesday | News
Experts in Tokyo design a novel flourescent probe

A team of experts at the University of Tokyo's Institute of Industrial Science (IIS) has developed a new probe that coul...

January 25, 2018 | Thursday | News
HITACHI secures FDA 510(k) Clearance for its system

Hitachi, Ltd. and Hokkaido University announced that it has obtained U.S. Food & Drug Administration (FDA) 510(k) cl...

January 25, 2018 | Thursday | News
Astellas completes acquisition of Mitobridge

Tokyo based Astellas Pharma Inc. recently announced the acquisition of Mitobridge, Inc. Astellas paid $225 million to ac...

January 24, 2018 | Wednesday | News
Japan approves use of Nailin capsules to treat onychomycosis

Sato Pharmaceutical Co., Ltd. has obtained marketing and manufacturing approval for the oral antifungal agent, Nailin ca...

January 22, 2018 | Monday | News
Telix Pharmaceuticals establishes Japanese Subsidiary, Appoints Key Executives

Telix Pharmaceuticals , an Australian biopharmaceutical company focused on the development of diagnostic and therapeutic...

January 15, 2018 | Monday | News
Japanese investors back a Cambridge Life Sciences firm, Storm Therapeutics

Storm Therapeutics, a Cambridge Life Sciences firm has attracted an additional £4m cash injection to its £12...

January 12, 2018 | Friday | News
Takeda to buy TiGenix for $626 M

Takeda Pharmaceutical is planning to acquire Belgian biopharmaceutical venture TiGenix with an aim of strengthening...

January 7, 2018 | Sunday | News
Alexion bags Japanese approval for Soliris

Alexion Pharmaceuticals, recently bagged approval for its key candidate Soliris (eculizumab) fromthe Ministry of Health,...

January 3, 2018 | Wednesday | News
Researchers in Japan develop new strategy for 3D printing of tissues

A group of researchers at Osaka University, Japan have refined the method of making bio-ink droplets stick to each other...

December 28, 2017 | Thursday | News
Otsuka collaborates with X-Chem for new drug compounds

US based X-Chem, Inc. and Otsuka Pharmaceutical Co., Ltd., a subsidiary of Otsuka Holdings Co., Ltd. headquartered in To...

December 26, 2017 | Tuesday | News
Japanese scientists create a database of human plasma compounds

Scientists at Tohoku University in Japan have created a database of metabolites from blood samples collected from over 5...

December 26, 2017 | Tuesday | News
Israeli firm to invest in Japanese startups

Israel based Yozma Group is planning to invest in Japanese startups in the coming year, targeting companies in medicine,...

December 14, 2017 | Thursday | News
Kenya partners with Japan to promote healthcare

The Kenyan government has collaborated with the government of Japan and launched a health development program that seeks...

December 4, 2017 | Monday | News

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls